David Roulois
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- interferon and immune responses
Papers in
- Immunology 14
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 5
- IL-33, ST2, and ILC Pathways 4
- T-cell and B-cell Immunology 4
- Immune cells in cancer 2
- Oncology 6
- Co-authors
- Daniel Diniz De Carvalho (3 shared papers)Helen Loo Yau (2 shared papers)Rajat Singhania (2 shared papers)Catherine Adell O'Brien (1 shared paper)Han Han (1 shared paper)Gangning Liang (1 shared paper)Yadong Wang (1 shared paper)Peter Anthony Jones (1 shared paper)
- Journals
- Oncotarget (3 papers)Immunity (2 papers)Epigenomics (1 paper)Science Advances (1 paper)OncoImmunology (1 paper)
- Partner nations
- FranceCanadaUnited Kingdom
In The Last Decade
David Roulois
22 papers receiving 2.6k citations
David Roulois's Hit Papers
Peers
Comparison fields: 5 of 89
- Cancer Research 645
- Immunology 752
- Oncology 659
- Molecular Biology 1.4k
- Genetics 138
Countries citing papers authored by David Roulois
This map shows the geographic impact of David Roulois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Roulois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Roulois more than expected).
Fields of papers citing papers by David Roulois
This network shows the impact of papers produced by David Roulois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Roulois. The network helps show where David Roulois may publish in the future.
Co-authors
The 25 scholars most cited alongside David Roulois, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts Hit paper breakdown → | 2015 | 1168 |
| 2 | Sensitive tumour detection and classification using plasma cell-free DNA methylomes Hit paper breakdown → | 2018 | 706 |
| 3 | 2019 | 171 | |
| 4 | 2013 | 103 | |
| 5 | 2021 | 74 | |
| 6 | 2019 | 67 | |
| 7 | 2021 | 50 | |
| 8 | 2012 | 36 | |
| 9 | 2015 | 35 | |
| 10 | 2012 | 32 | |
| 11 | 2015 | 26 | |
| 12 | 2016 | 23 | |
| 13 | 2021 | 23 | |
| 14 | 2022 | 21 | |
| 15 | 2016 | 15 | |
| 16 | 2011 | 14 | |
| 17 | 2011 | 13 | |
| 18 | 2019 | 13 | |
| 19 | 2021 | 9 | |
| 20 | 2022 | 7 |
About David Roulois
David Roulois is a scholar working on Immunology, Oncology, Cancer Research, Molecular Biology and Genetics, having authored 24 papers that have together received 2.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (5 papers), IL-33, ST2, and ILC Pathways (4 papers), T-cell and B-cell Immunology (4 papers), Cancer-related molecular mechanisms research (2 papers), Occupational and environmental lung diseases (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Cancer Research (645 citations), Immunology (752 citations), Oncology (659 citations), Molecular Biology (1.4k citations) and Genetics (138 citations). David Roulois has collaborated with scholars based in France, Canada and United Kingdom. Frequent co-authors include Daniel Diniz De Carvalho, Helen Loo Yau, Rajat Singhania, Catherine Adell O'Brien, Han Han, Gangning Liang, Yadong Wang, Peter Anthony Jones, Trevor J. Pugh and Shu Yi Shen. Their work appears in journals such as Oncotarget, Immunity, Epigenomics, Science Advances and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.